Skip to main content
Log in

Pain reduction during and after insertion of an intrauterine contraceptive device

  • Published:
Advances in Contraception

Abstract

The intrauterine contraceptive device (IUD) is an establshed method of fertility regulation despite certain problems. The major problems relating to IUD use are unwanted pregnancy, excessive bleeding, genital infection, occasional uterine perforation, device translocation, and pelvic pain. All fertility regulation personnel are aware that a very large number of potential IUD acceptors are concerned about the possibility of pain before, during and after device insertion.

Pain is recognized as one of the major reasons for termination of the use of the IUD. Despite this, and unlike other IUD problems, IUD-related pain has been very poorly studied. At a recent workshop on intrauterine contraception there was not one presentation on this topic [1]. The reason for this is that IUD-related pain is difficult to study, requiring careful analysis of subjective rather than objective data. Nevertheless a thorough understanding of the mechanisms, causes, prevention and treatment of IUD-related pain is important for fertility regulators in both developed and developing countries.

Resumé

Malgré certains problèmes, la pose d'un dispositif contraceptif inter-utérin (DIU) est une méthode établie de régulation de la fertilité. Les principaux problèmes liés à l'utilisation des DIU sont les suivants: grossesses involontaires, saignements excessifs, infections génitales, parfois perforations utérines, déplacement du dispositif et douleurs pelviennes. Les responsables de la régulation de la fertilité sont tous conscients du fait qu'un très grand nombre de femmes qui accepterainent éventuellement d'utiliser un DIU sont préoccupées par la possibilité de douleurs avant, pendant et après la mise en place d'un dispositif.

Il est admis que l'abandon d'un DIU est déterminé dans la plupart des cas par les doulers qu'il occasionne. Pourtant, au contraire d'autres problèmes liés aux DIU, les douleurs qu'ils peuvent causer ont été fort peu étudiées. A des journées de travail sur la contraception interutérine tenues récemment, aucune communication à ce sujet n'a été présentée [1]. Cette lacune provient de ce qu'il est difficile de mener une étude sur les douleurs liées à l'utilisation des DIU, celle-ci nécessitant une analyse de données subjectives plutôt qu'objectives. Il est néanmoins essentiel, pour les responsables de la régulation de la fertilité, aussi bien dans les pays développés que dans les pays en développement, de compre à fond les mécanismes, les causes, la prévention et le traitement des douleurs liées à l'utilisation des DIU.

Resumen

Pese a ciertos problemas, el dispositivo anticonceptivo intrauterino (DIU) es un método reconocido para la regulación de la fertilidad. Los mayores problemas relacionados con el uso de DIU son: embarazo no deseado, sangrado excesivo, infección genital, perforación uterina ocasional, dispositivo cambiado de sitio y dolor pelviano. El personal que regula la fertilidad tiene conciencia que a un gran número de potenciales aceptantes de DIU les preocupa la posibilidad de dolor antes, durante y después de la inserción del dispositivo.

El dolor está reconocido como una de las mayores razones para la terminación del uso de DIU. Pese a esto, y a diferencia con otros problemas conectados con los DIU, el dolor relacionado con ellos ha sido muy poco estudiado. En una reciente reunión de trabajo sobre anticoncepción intrauterina, no hubo ninguna presentación sobre este tópico [1]. La razón de esto es que el dolor relacionado con los DIU es difícil de estudiar y requiere un cuidadoso análisis de datos subjetivos más que objetivos. Sin embargo, la comprensión absoluta del mecanismo, las causas, la prevención y el tratamiento del dolor relacionado con los DIU es importante para la regulación de la fertilidad, tanto en los países desarrollados como en aquellos en desarrollo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. ZatuchniG. I., GoldsmithA. and SciarraJ. J., eds. (1985).Intrauterine Contraception-Advances and Future Prospects. Proceedings of an International Workshop on Intrauterine Contraception, May 29–June 1, 1984, Harper and Row, Philadelphia

    Google Scholar 

  2. RenaerM. (1981).Chronic Pelvic Pain in Women. Springer-Verlag, Berlin, p. 4

    Google Scholar 

  3. GoldstuckN. D. (1979). The management of intrauterine device related pain.Br. J. Fam. Plann.,5, 63–65

    Google Scholar 

  4. SnyderS. H. (1979). Opiate receptors and internal opiates.Sci. Am.,236(3), 44–56

    Google Scholar 

  5. DawoodM. Y. (1985). Dysmenorrhoea.J. Reprod. Med.,30, 154–167

    PubMed  Google Scholar 

  6. YlikorkalaO. and DawoodM. Y. (1978). New concepts in dysmenorrhoea.Am. J. Obstet. Gynecol.,130, 833–847

    PubMed  Google Scholar 

  7. LaatikainenT., RaisanenI., TulenkeimoA., et al. (1985). Plasma β-endorphin and the menstrual cycle.Fertil. Steril.,44, 206–209

    PubMed  Google Scholar 

  8. StrömbergP., AkerlundM., ForslingM. L., et al. (1984). Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhoea.Acta. Obstet. Gynecol. Scand.,63, 533–538

    PubMed  Google Scholar 

  9. YenS. S. C., QuigleyM. E., ReidR. L., et al. (1985). Neuroendocrinology of opioid peptides and their role in the control of gonadotrophin and prolactin secretion.Am. J. Obstet. Gynecol.,152, 485–493

    PubMed  Google Scholar 

  10. NewtonJ. R. and ReadingA. E. (1977). The effects of psychological preparation on pain at intrauterine device insertion.Contraception,16, 523–536

    PubMed  Google Scholar 

  11. ReadingA. E., ReedC. and NewtonJ. R. (1979). A card sort method for pain assessment in gynaecology: a multi-dimensional approach.Acta. Obstet. Gynecol. Scand.,58, 105–113

    PubMed  Google Scholar 

  12. Discussion, IUCD Workshop, London (1982).Br. J. Obstet. Gynaecol., Suppl. 4, 18–19

    Google Scholar 

  13. ElsteinM. (1982). IUCD liability.Br. J. Obstet. Gynaecol, Suppl.4, 11–17

    Google Scholar 

  14. GrahamS. and SimcockB. W. (1982). A review of the use of intrauterine devices in nulliparous women.Contraception,26, 323–346

    PubMed  Google Scholar 

  15. WhiteM. K., OryH. W., RooksJ. B., et al. (1980). Intrauterine device termination rates and the menstrual cycle day of insertion.Obstet. Gynecol.,55, 220–224

    PubMed  Google Scholar 

  16. GoldstuckN. D. (1979). Insertion of intrauterine devices. Some technical considerations.Practitioner,223, 647–651

    PubMed  Google Scholar 

  17. GoldstuckN. D. and MatthewsM. L. (1985). A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device.Clin. Reprod. Fertil.,3, 65–71

    PubMed  Google Scholar 

  18. GoldstuckN. D. (1985). Clinical uterine measuring techniques and their relevance to IUCD choice and performance.Br. J. Sex. Med.,12, 8–10

    Google Scholar 

  19. GoldstuckN. D. (1981). A comparison of the initial pain response following insertion of the Copper 7 and Combined Multiload 250-short IUDs.Contracept. Deliv. Syst.,2, 295–301

    PubMed  Google Scholar 

  20. GoldstuckN. D. and MatthewsM. L. (1985). A comparison of the actual and expected pain response following removal of an IUCD.Adv. Contracept. Deliv. Syst.,1, 122–125

    PubMed  Google Scholar 

  21. GoldstuckN. D. and WardP. J. (1983). Treatment of pain following IUD insertion with Meptazinol-a new centrally acting analgesic.Contracept. Deliv. Syst.,4, 33–37

    PubMed  Google Scholar 

  22. GuillebandJ. and BoundsW. (1983). Control of pain associated with intrauterine device insertion using mefenamic acid.Res. Clin. Forum,5, 69–73

    Google Scholar 

  23. HassonH. M. (1977). Topical uterine anaesthesia — a preliminary report.Int. J. Gynaecol. Obstet.,15, 238–240

    PubMed  Google Scholar 

  24. HassonH. M. (1984). Topical uterine anaesthesia for IUD insertion. In:Biomedical Aspects of IUDs, H. M.Hasson, W. A. A.vanOs and E. S. E.Hafez, eds., MTP Press, Lancaster, UK, pp. 89–97

    Google Scholar 

  25. HepburnS. (1980). Method of local anaesthesia for IUD insertion.Contracept. Deliv. Syst.,1, 371–382

    PubMed  Google Scholar 

  26. KurzK. H. and Meier-OelkeP. (1983). Jet injection-local anaesthesia for fitting and removal of IUDs.Contracept. Deliv. Syst.,4, 27–32

    PubMed  Google Scholar 

  27. LippesJ., MalikT. and TatumH. J. (1976). The post-coital Copper-T.Adv. Plann. Parent.,11, 24–29

    PubMed  Google Scholar 

  28. SnowdenR. (1982). General assessment of the multiload Cu250 intrauterine device. UK network of IUCD research clinics.Br. J. Obstet. Gynaecol., Suppl. 4, 58–65

    Google Scholar 

  29. ButtramV., IzuA. and HenzlM. R. (1979). Naproxen sodium in uterine pain following intrauterine device insertion.Am. J. Obstet. Gynecol.,134, 575–581

    PubMed  Google Scholar 

  30. MasseyS. E., VaradyJ. C. and HenzlM. R. (1974). Pain relief with Naproxen following insertion of an intrauterine device.J. Reprod. Med.,13, 226–231

    PubMed  Google Scholar 

  31. RoyS. and ShawS. T. (1981). Role of prostaglandins in IUD associated uterine bleeding: Effect of a prostaglandin synthetase inhibitor (ibuprofen).Obstet. Gynecol.,58, 101–106

    PubMed  Google Scholar 

  32. ReadingA. E. and GoldstuckN. D. (1981). The influence of clinic factors on IUD continuation.Eugen. Bull.,13, 117–124

    Google Scholar 

  33. ReadingA. E. and GoldstuckN. D. (1982). Effect of clinic related factors on continuation rates of IUDs.Contracept. Deliv. Syst.,3, 1–9

    PubMed  Google Scholar 

  34. GoldstuckN. D. (1981). Pain response following insertion of a Gravigard (Copper 7) intrauterine contraceptive device in nulliparous women.Int. J. Fertil.,26, 53–56

    PubMed  Google Scholar 

  35. AbdallaM. I., IbrahimI. I. and BayadM. A. (1985). Hysterographic uterine measurements and clinical endocrinologic implications. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds, Harper and Row, Philadelphia, p. 163

    Google Scholar 

  36. AbdallaM. I., KamalI., OsmanM. I., et al. (1981). Dimensional and architectural disproportion between the IUD and the uterine cavity: a cause of complications.Contracept. Deliv. Syst.,2, 31–35

    PubMed  Google Scholar 

  37. KamalI. (1979). Atlas of hysterographic studies of the ‘IUD-holding uterus’. Mode of action and evaluation of size effects on intrauterine contraception. International Research Centre, Ottawa, Canada, p. 23

    Google Scholar 

  38. KurzK. H. (1981). Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.Contracept. Deliv. Syst.,2, 21–29

    PubMed  Google Scholar 

  39. LuukkainenT., AllonenM., NygrenK. G., et al. (1985). Five years' experience with the Nova-T and T-Cu IUDs. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds., Harper and Row, Philadelphia, p. 79

    Google Scholar 

  40. PoppL. (1985). X-Ray and ultrasound in IUD management. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds., Harper and Row, Philadelphia, p. 232

    Google Scholar 

  41. TejujaS. and MalkaniP. K. (1969). Clinical significance of correlation between size of uterine cavity and IUD: a study by planimeter-hysterogram technique.Am. J. Obstet. Gynecol.,105, 620–627

    PubMed  Google Scholar 

  42. YlikorkalaO., KauppilaA. and SiljanderM. (1978). Antiprostaglandin therapy in prevention of side effects of intrauterine contraceptive devices.Lancet,2, 393–395

    PubMed  Google Scholar 

  43. RubinA. (1972). Complications due to Lippes Loop. Report of a death and other complications seen over an 18-month period at Baragwanath Hospital.South Afr. J. Obstet. Gynaecol.,10, 45–48

    Google Scholar 

  44. ZakinD., SternW. Z. and RosenblattR. (1981). Complete and partial uterine perforation and embedding following insertion of intrauterine devices. I. Classification, complications, mechanism, incidence and missing string.Obstet. Gynecol. Surv.,36, 335–353

    PubMed  Google Scholar 

  45. ReadingA. E. and NewtonJ. R. (1977). A comparison of primary dysmenorrhoea and intrauterine device related pain.Pain,3, 265–276

    PubMed  Google Scholar 

  46. HaukkamaaM., AllonenM., HeikilaM., et al. (1985). Long-term clinical experience with levonorgestrel releasing IUD. In:Intrauterine Contraception-Advances and Future Prospects, G. I.Zatuchni, A.Goldsmith and J. J.Sciarra, eds., Harper and Row, Philadelphia, p. 232

    Google Scholar 

  47. PizzarroP., Gomez-RogersC. and RoweP. J. (1979). Comparative study of the effect of Progestasert and Gravigard IUDs on dysmenorrhoea.Contraception,20, 455–466

    PubMed  Google Scholar 

  48. TroboughG., GuderianA. M., EricksonR. R., et al. (1978). The effect of exogenous intrauterine progesterone on the amount and prostaglandin F2-α content of menstrual blood in dysmenorrhoeic women.J. Reprod. Med.,21, 153–156

    PubMed  Google Scholar 

  49. BergerG. S., EdelmanD. A. and RegenieS. A. (1976). Patients' response to IUD insertion.Int. J. Obstet. Gynaecol.,14, 147–152

    Google Scholar 

  50. HagerW. D., EschenbachD. A., SpenceM. R., et al. (1983). Criteria for diagnosis and grading of salpingitis.Obstet. Gynecol.,61, 113–114

    PubMed  Google Scholar 

  51. LedgerW. (1983). Diagnosis and treatment of salpingitis.J. Reprod. Med.,28(10S), 709–711

    PubMed  Google Scholar 

  52. SweetR. L. (1981). Pelvic inflammatory disase: etiology, diagnosis and treatment.Sex. Transm. Dis.,8 (Suppl. 4), 308–315

    PubMed  Google Scholar 

  53. GoldstuckN. D. (1982). The IUCD in nulliparous women: with special reference to the Multiload Copper 259 ‘mini’ and short IUCDs.Br. J. Obstet. Gynaecol., Suppl. 4, 54–57

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldstuck, N.D. Pain reduction during and after insertion of an intrauterine contraceptive device. Adv Contracept 3, 25–36 (1987). https://doi.org/10.1007/BF01849250

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849250

Keywords

Navigation